MEMORANDUM OPINION
SLIGHTS, Vice Chancellor.
In May 2015, Teva Pharmaceuticals Industries, Inc. acquired Auspex Pharmaceuticals, Inc. in a two-step, medium-form merger pursuant to Section 251(h) of the Delaware General Corporation Law. No Auspex stockholders sought to enjoin the transaction. Plaintiffs are former stockholders of Auspex...
Let's get started
Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.
- Updated daily.
- Uncompromising quality.
- Complete, Accurate, Current.